PTH and Marchiafava-Bignami disease: Active vitamin D compounds may ameliorate post-transplantation CKD–MBD by many mechanisms, feasibly suppressing PTH secretion, reducing glucocorticoid-induced decreases in intestinal calcium absorption, and promoting differentiation of osteoblast precursors into mature cells.